Skip to main content
Equibles
INBX $95.30 +6.14%
INBX logo
INBX · Inhibrx Biosciences, Inc.
Track INBX — free

Use INBX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INBX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$95.30 +5.51 (+6.14%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.32B
Shares
14.72M
Volume · Oct 20 221.46K Avg daily vol (3M) 274.07K
All webcasts

Earnings call · FY2025 Q3

Inhibrx Biosciences, Inc. (INBX) Q3 2025 Earnings Call

Concluded Nov 14, 2025
Nov 14, 2025 0 turns
Period
FY2025 Q3
Runtime
—
Sources
2 artifacts
Revenue $0
Diluted EPS -$2.28
Net income -$35.26M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 14, 2025 10-Q report Filed Nov 14, 2025 Company webcastOpen the original investor-relations page
Full-screen source Call document

INBX alerts

Inhibrx Biosciences, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →